Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1996-09-09
Original market date: See footnote 1
1973-12-31
Product name:
TEGOPEN INJ 250MG/VIAL
DIN:
00407593 Electronic product monograph is not available
Company:
BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
300
2344 Boul. Alfred Nobel
Montreal
Quebec
Canada
H4S 0A4
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intramuscular , Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.16.12
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01CF02 CLOXACILLIN
Active ingredient group (AIG) number:See footnote5
0105904001
Active ingredient(s) | Strength |
---|---|
CLOXACILLIN SODIUM | 250 MG / VIAL |